AstraZeneca Pharma India has reported a total income of Rs 178.30 crores during the period ended June 30, 2021, as compared to Rs.212.80 crores during the period ended March 31, 2021. The company reported an income of Rs 196.22 crores during the period ended June 30, 2020

The company has posted a net profit of Rs.10.24 crores for the period ended June 30, 2021, as against a net profit of Rs.27.27 crores for the period ended March 31, 2021. The company had reported a net profit of Rs 18.83 crores during the period ended June 30, 2020.

The company has reported EPS of Rs.4.10 for the period ended June 30, 2021, as compared to Rs.10.91 for the period ended March 31, 2021. For the period ended June 30, 2020, the EPS stood at Rs 7.46.

In another development, the Board of Directors of AstraZeneca Pharma India Ltd at its meeting held on August 09, 2021, has declared an Interim Dividend of Rs. 2 per equity share for the financial year 2021-22.